cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Agus Prima
Contact Email
chairman@jsocmed.org
Phone
+6281269200232
Journal Mail Official
chairman@jsocmed.org
Editorial Address
Jl. DR. Wahidin Sudiro Husodo No.243B, Kembangan, Klangonan, Kec. Kebomas, Kabupaten Gresik, Jawa Timur 61124
Location
Kab. gresik,
Jawa timur
INDONESIA
The Journal of Society Medicine (JSOCMED)
Published by PT. CoinReads Media Prima
ISSN : -     EISSN : 29645565     DOI : https://doi.org/10.47353/jsocmed.v2i1
Core Subject : Health, Science,
Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience
The Journal of Society Medicine (JSOCMED) | ISSN (e): 2964-5565 is a leading voice in the Indonesia and internationally for medicine and healthcare. Published continuously, JSOCMED features scholarly comment and clinical research. JSOCMED is editorially independent from and its The Editor-in-Chief (EIC) is Prof. dr. Aznan Lelo, PhD, SpFK. JSOCMED offers many attractive features for authors, including free online access to all research articles, online publication ahead of print, and online responses to articles published as Quick Comments. In addition, as befitting a publication of the Journal of Society Medicine, JSOCMED implements best practice in scientific publishing with an open peer review process, declarations of competing interests and funding, full requirements for patient consent and ethical review, and statements of guarantorship, contributorship, and provenance.
Arjuna Subject : Kedokteran - Kedokteran (Lain-Lain)
Articles 5 Documents
 1 
Search results for , issue "Vol. 4 No. 10 (2025): October" : 5 Documents clear
Minimally Invasive Correction of Proximal Phalanx Malunion Using Cannulated Headless Screws: A Case Series Sibarani, Jonathan Junius; Satria, Oryza; Aprilya, Dina
Journal of Society Medicine Vol. 4 No. 10 (2025): October
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i10.236

Abstract

Introduction: Malunion of the proximal phalanx can result in significant aesthetic and functional impairments, including malrotation, finger scissoring, and diminished grip strength. Conventional treatment involves open osteotomy with plate and screw fixation, which is associated with drawbacks such as surgical site scarring, prolonged rehabilitation, and tendon or soft tissue adhesions. This case series evaluates a minimally invasive technique using cannulated headless screws as an alternative approach for correcting proximal phalanx malunion. Methods: Three patients with proximal phalanx malunion underwent a minimally invasive procedure. The technique involved two small incisions: one for osteotomy and another for guide wire insertion, followed by fixation with a cannulated headless screw under fluoroscopic guidance. Postoperative outcomes were assessed at three months, focusing on hand function, deformity correction, and complications. Results: At the three-month follow-up, all patients demonstrated significant improvements in hand function, with restored alignment and no reported malrotation or scissoring. Grip strength was enhanced, and no complications, such as infection or hardware failure, were observed. Patients reported minimal scarring and faster recovery compared to traditional open approaches. Conclusion: The minimally invasive approach using cannulated headless screws offers a promising alternative for correcting proximal phalanx malunion. It minimizes soft tissue trauma, reduces scarring, and promotes faster rehabilitation while achieving favorable functional outcomes. Further studies with larger cohorts are warranted to validate the efficacy and long-term outcomes of this technique.
Clinical Hirsutism Secondary to Ovarian Clear Cell Carcinoma: A Rare Case Report Muknisa, Liza; Nainggolan, Sarah Ika Nainggolan; Rusnaidi, Rusnaidi; Septivera, Yusra
Journal of Society Medicine Vol. 4 No. 10 (2025): October
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i10.240

Abstract

Introduction: Hirsutism affects 5–15% of premenopausal women, predominantly due to hyperandrogenemia (80–90% of cases), with the remainder classified as idiopathic or normoandrogenic. While virilizing ovarian tumors are known causes, the association between hirsutism and ovarian clear cell carcinoma (OCCC) has not been previously documented. Case Description: A 51-year-old multiparous woman presented with progressive abdominal distension over one year and new-onset hirsutism (Ferriman–Gallwey score 13) involving the face, axillae, pubic area, and lower limbs. She reported abdominal pain, nausea, vomiting, anorexia, 5-kg weight loss, vaginal discharge, regular menses, and poorly controlled type 2 diabetes. Examination revealed an underweight habitus and a firm, irregular, mobile, tender pelvic-abdominal mass extending above the umbilicus. Laboratory evaluation showed hypoalbuminemia (3.22 g/dL), elevated creatinine (1.64 mg/dL), markedly raised CA-125 (1,480 U/mL), and normal serum testosterone (7.5 ng/dL). Imaging confirmed a 9.5 × 8.3 × 5.5 cm solid-cystic right ovarian mass with ascites and suspected peritoneal metastases. Total abdominal hysterectomy with surgical staging was performed; histopathology confirmed OCCC. Conclusion: This is the first reported case of clinical hirsutism in OCCC with normal testosterone levels, supporting a diagnosis of idiopathic hirsutism. Potential mechanisms include increased peripheral 5α-reductase activity, androgen receptor hypersensitivity, or local androgen production, warranting further molecular investigation.
Association Between Indoxyl Sulfate Levels and Major Cardiovascular Events in Hemodialysis Patients with Chronic Kidney Disease Suhendra, Adi; Ramadani , Sumi; Tarigan , Radar Radius
Journal of Society Medicine Vol. 4 No. 10 (2025): October
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i10.259

Abstract

Introduction: Chronic kidney disease (CKD) markedly reduces quality of life and increases mortality risk, predominantly due to cardiovascular complications. Indoxyl sulfate, a protein-bound uremic toxin, is increasingly recognized for its role in accelerating cardiovascular disease in CKD patients. This study aims to evaluate the association between indoxyl sulfate levels and major cardiovascular events (MCE) in patients with stage 5 CKD undergoing hemodialysis. Methods: This observational case-control study included 50 patients with stage 5 CKD on hemodialysis. Inclusion criteria were informed consent, willingness to undergo laboratory assessments, and a confirmed CKD diagnosis. Patients with a history of acute myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, cardiac arrest, arrhythmias, or incomplete laboratory data were excluded. Serum indoxyl sulfate, creatinine, urea, and estimated glomerular filtration rate (eGFR) were measured. Statistical analyses, including t-tests and logistic regression, were used to compare clinical parameters between patients with and without MCE. Results: Of the 50 patients (mean age: 55.4 ± 8.2 years for MCE group, 47.8 ± 7.9 years for non-MCE group; p=0.015), 29 experienced MCE, and 21 did not. Hemodialysis duration averaged 15.9 ± 4.3 years (MCE) versus 25.9 ± 5.1 years (non-MCE; p=0.005). Significant differences were found in creatinine (p=0.014), creatinine-urea ratio (p=0.007), and eGFR (p<0.001). Elevated indoxyl sulfate levels were strongly associated with MCE (p=0.001). Conclusion: Higher indoxyl sulfate levels are significantly correlated with major cardiovascular events in hemodialysis-dependent CKD patients, underscoring its potential as a predictive biomarker for cardiovascular risk.
Comparative Analysis of Ankle-Brachial Index in Chronic Myeloid Leukemia Patients Treated with Imatinib versus Nilotinib at Adam Malik Hospital Alfajri, Muhammad Jailani Alfajri; Syahrini Lubis, Henni; Gatot, Dairion
Journal of Society Medicine Vol. 4 No. 10 (2025): October
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i10.260

Abstract

Introduction: Chronic myeloid leukemia (CML) is commonly managed with tyrosine kinase inhibitors (TKIs) such as imatinib and nilotinib. However, these therapies are associated with cardiovascular risks, including peripheral arterial disease (PAD). This study compares the Ankle-Brachial Index (ABI), a non-invasive measure of PAD, in CML patients receiving imatinib or nilotinib at Adam Malik Hospital, Medan. Methods: A cross-sectional study was conducted from December 2023 to February 2024 at Adam Malik Hospital. Forty-eight CML patients (34 on imatinib, 14 on nilotinib) were enrolled using consecutive sampling. ABI was measured to assess PAD prevalence, with values <0.9 indicating abnormality. Data were analyzed using independent t-tests and chi-square tests, with significance set at p<0.05. Results: The mean age was 42.9 years (imatinib) and 49.1 years (nilotinib). Abnormal ABI values were observed in 20.6% (7/34) of imatinib-treated patients and 50% (7/14) of nilotinib-treated patients. The mean ABI for the left leg was significantly lower in the nilotinib group (0.91 ± 0.12) compared to the imatinib group (1.06 ± 0.11, p=0.017). A significant difference in ABI values between groups was confirmed (p=0.042, odds ratio 3.857), indicating a higher PAD risk with nilotinib. Conclusion: Nilotinib therapy is associated with a higher incidence of PAD compared to imatinib in CML patients. These findings underscore the need for routine cardiovascular monitoring in TKI-treated patients and further research into the vascular effects of TKIs.
Anesthesia Management for Esophageal Atresia Feryadi, Rahmat; Riswandi, Riswandi
Journal of Society Medicine Vol. 4 No. 10 (2025): October
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.71197/jsocmed.v4i10.261

Abstract

Introduction: Esophageal atresia (EA), a congenital anomaly characterized by esophageal discontinuity, often accompanied by tracheoesophageal fistula (TEF), necessitates urgent surgical intervention. This report outlines the anesthesia management for a 9-day-old male infant with EA treated at Zainoel Abidin General Hospital, Banda Aceh. Case Description: The patient presented with clinical symptoms including swallowing difficulty, excessive salivation, and vomiting during feeding, confirmed by nasogastric tube insertion and radiological examination. Initial management involved emergency gastrostomy and esophagostomy for decompression, followed by thoracotomy and esophageal repair using the Foker technique. General anesthesia combined with caudal regional anesthesia was employed to ensure hemodynamic stability and minimize intraoperative opioid requirements. Key anesthetic challenges included the risk of aspiration, difficult airway management, and maintenance of fluid balance and body temperature in a neonate. Postoperatively, the patient was admitted to the neonatal intensive care unit (NICU) with ventilator support, rigorous hemodynamic monitoring, and antibiotic therapy to prevent complications such as infection and respiratory distress. Conclusion: A multidisciplinary anesthetic approach was critical to the successful surgical correction of EA. Early and comprehensive management resulted in a favorable prognosis, highlighting the importance of tailored anesthesia strategies in neonatal surgery.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2025 2025


Reset
Filter By Issues
All Issue Vol. 4 No. 12 (2025): December Vol. 4 No. 11 (2025): November Vol. 4 No. 10 (2025): October Vol. 4 No. 9 (2025): September Vol. 4 No. 8 (2025): August Vol. 4 No. 7 (2025): July Vol. 4 No. 6 (2025): June Vol. 4 No. 5 (2025): May Vol. 4 No. 4 (2025): April Vol. 4 No. 3 (2025): March Vol. 4 No. 2 (2025): February Vol. 4 No. 1 (2025): January Vol. 3 No. 12 (2024): December Vol. 3 No. 11 (2024): November Vol. 3 No. 10 (2024): Oktober Vol. 3 No. 9 (2024): September Vol. 3 No. 8 (2024): August Vol. 3 No. 7 (2024): July Vol. 3 No. 6 (2024): June Vol. 3 No. 5 (2024): May Vol. 3 No. 4 (2024): April Vol. 3 No. 3 (2024): March Vol. 3 No. 2 (2024): February Vol. 3 No. 1 (2024): January Vol. 2 No. 12 (2023): December Vol. 2 No. 11 (2023): November Vol. 2 No. 10 (2023): October Vol. 2 No. 9 (2023): September Vol. 2 No. 8 (2023): August Vol. 2 No. 7 (2023): July Vol. 2 No. 6 (2023): June Vol. 2 No. 5 (2023): May Vol. 2 No. 4 (2023): April Vol. 2 No. 3 (2023): March Vol. 2 No. 2 (2023): February Vol. 2 No. 1 (2023): January Vol. 1 No. 3 (2022): December Vol. 1 No. 2 (2022): November Vol. 1 No. 1 (2022): October More Issue